Their cost-effectiveness and favorable pharmacokinetic properties (e.g., efficient absorption and potent bioactivity) make them attractive candidates for localized and targeted wound therapies [29, 54-57]
No guessing how much you're absorbing, no extra steps
Together these molecules constitute the **reference pairing** in tendon, ligament, muscle and vascular repair research: two complementary mechanisms of action, one shared angiogenic vector, and dramatically expanded tissue coverage
And its amazing for people. Brigham Buhler, owner of a telehealth company and a mail-order compounding pharmacy, took a similar tone in a 2023 episode of Joe Rogans podcast
Where an acute strain might respond within two to three weeks, chronic tendinopathies may need eight to twelve weeks of consistent micro-dosing before significant improvement becomes apparent